Promote the discovery of early markers in asymptomatic people at risk for dementia
Explore new therapeutic targets for disease modification or prevention
Identify new outcome measures for efficacy of disease modifying treatments
Harmonization of international, multicenters large-scale prevention trials
Recruitment and retention of asymptomatic subject/volunteers for prevention trials
International regulatory issues
Assessing the impact of clinical trials on today’s medical practice
Design of case report forms and other data-collecting methods for clinical trials
General or specific designs and operating features for data processing systems used for maintaining databases clinical trials
Management of multicenter investigations
Methods for assessing patient's compliance
Organizational structures for facilitating multicenter investigations
Statistical methods for clinical trials
Study design and clinical endpoints
AD Primary Preventive Trials
AD Secondary Preventive Trials
AD Disease-modifying trials
AD Symptomatic trials
Trials in severe dementias
Trials in other dementias : Parkinson dementia - Vascular dementia - Frontal dementia
CSF biomarkers
Neuroimaging biomarkers : MRI, fMRI, PETscan, SPECT...
Plasma biomarkers
Immunotherapies
α and β secretase inhibitors
Paul AISEN (San Diego)
Kaj BLENNOW (Molndal)
Merce BOADA (Barcelona)
Maria CARRILLO (Chicago)
Bruno DUBOIS (Paris)
Howard FELDMAN (Vancouver)
Giovanni B. FRISONI (Brescia)
Lutz FROELICH (Mannheim)
Serge GAUTHIER (Montreal)
Ezio GIACOBINI (Geneva)
Michael GRUNDMANN (San Diego)
Zaven KHACHATURIAN (Washington DC)
Virginia LEE (Philadelphia)
Jean-Marc ORGOGOZO (Bordeaux)
Ronald PETERSEN (Minnesota)
Lon SCHNEIDER (Los Angeles)
Eric SIEMERS (Philadelphia)
Peter SNYDER (Rhode Island)
Yaakov STERN (New York)
Jacques TOUCHON (Montpellier)
John TROJANOWSKI (Philadelphia)
Bruno VELLAS (Toulouse)
Michael W. WEINER (San Francisco)
Bengt WINBLAD (Stockholm)
Paul AISEN
Merce BOADA
Jacques TOUCHON
Bruno VELLAS
Zaven KACHATURIAN
Michael WEINER
ANT Congrès
154 avenue de Lodève
34070 Montpellier
France
E-mail :
Tel : + 33 (0)4 67 10 92 23
Mobile: +33 6 85 54 70 98
ANT Congrès - 154 avenue de Lodève - 34070 Montpellier - France
E-mail : ctad@ant-congres.com
Tel : + 33 (0) 6 85 54 70 98
Fax : + 33 (0)4 67 10 92 23